About this item:

53 Views | 20 Downloads

Author Notes:

Yun Liu, Box G-S121-2, Brown University, Providence, RI 02912 USA. Email: yun_lin@brown.edu

We are grateful to ECHO participants for the time they have given to our studies. We also thank our Child Health Outcomes (ECHO) Program colleagues, the medical, nursing and program staff, as well as the children and families participating in the ECHO cohorts. We acknowledge the contributions of the following ECHO Program collaborators: Coordinating Center—P.B. Smith, K.L. Newby, and D.K. Benjamin (Duke Clinical Research Institute, Durham, North Carolina); Data Analysis Center—L.P. Jacobson (Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland) and C.B. Parker (Research Triangle Institute, Durham, North Carolina); Human Health Exposure Analysis Resource—P. Parsons and K. Kurunthacalam (Wadsworth Center, Menands, New York) and T. Fennell, S. Sumner, and X. Du (RTI International, Research Triangle Park, North Carolina).

Subjects:

Research Funding:

Research reported in this publication was supported by the ECHO Program, Office of the Director, National Institutes of Health (NIH), under awards U2COD023375 (Coordinating Center), U24OD023382 (Data Analysis Center), U24OD023319 (PRO Core), and UG3OD023272 (to S.S.), UH3OD023313 (S.CL.D.), UH3OD023275 (to M.R.K.), UH3OD023248 (to D.D.), UH3OD023289 (to A.F.), UH3OD023349 (to T.G.O.), UH3OD023286 (to E.O.), UH3OD023272 (to S.S. and T.J.W.). This work was supported by National Institute of Environmental Health Sciences grants R01ES019196 (to A.F.), P01ES022848 (to S.S.), P01ES022841 (to T.J.W.), R01HD034568 (to E.O.), R01ES030101 (to A.F.F.), RD83543301 (to T.J.W.), and RD83543401 (to S.S.) and by National Institute of General Medicine grant P20GM104416 (to M.R.K.).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Environmental Sciences
  • Public, Environmental & Occupational Health
  • Toxicology
  • Environmental Sciences & Ecology
  • MATERNAL SERUM
  • PRENATAL EXPOSURE
  • EARLY-PREGNANCY
  • OBESITY
  • ADIPOSITY
  • PROJECT
  • FETAL
  • AGE

Associations of Gestational Perfluoroalkyl Substances Exposure with Early Childhood BMI z-Scores and Risk of Overweight/Obesity: Results from the ECHO Cohorts

Show all authors Show less authors

Tools:

Journal Title:

ENVIRONMENTAL HEALTH PERSPECTIVES

Volume:

Volume 131, Number 6

Publisher:

, Pages 67001-67001

Type of Work:

Article | Final Publisher PDF

Abstract:

BACKGROUND: Gestational per-and polyfluoroalkyl substances (PFAS) exposure may be associated with adiposity and increased risk of obesity among children and adolescents. However, results from epidemiological studies evaluating these associations are inconsistent. OBJECTIVES: We estimated the associations of pregnancy PFAS concentrations with child body mass index (BMI) z-scores and risk of overweight/ obesity in eight U.S. cohorts. METHODS: We used data from 1,391 mother–child pairs who enrolled in eight Environmental influences on Child Health Outcomes (ECHO) cohorts (enrolled: 1999–2019). We quantified concentrations of seven PFAS in maternal plasma or serum in pregnancy. We measured child weight and height between the ages of 2 and 5 y and calculated age-and sex-specific BMI z-scores; 19.6% children had more than one BMI measurement. We estimated covariate-adjusted associations of individual PFAS and their mixture with child BMI z-scores and risk of overweight/obesity using linear mixed models, modified Poisson regression models, and Bayesian approaches for mixtures. We explored whether child sex modified these associations. RESULTS: We observed a pattern of subtle positive associations of PFAS concentrations in pregnancy with BMI z-scores and risk of overweight/obesity. For instance, each doubling in perfluorohexane sulfonic acid concentrations was associated with higher BMI z-scores (b =0:07; 95% CI: 0.01, 0.12). Each doubling in perfluroundecanoic acid [relative risk ðRRÞ =1:10; 95% CI: 1.04, 1.16] and N-methyl perfluorooctane sulfonamido acetic acid (RR = 1:06; 95% CI: 1.00, 1.12) was associated with increased risk of overweight/obesity, with some evidence of a monotonic dose–response relation. We observed weaker and more imprecise associations of the PFAS mixture with BMI or risk of overweight/obesity. Associations did not differ by child sex. DISCUSSION: In eight U.S.-based prospective cohorts, gestational exposure to higher levels of PFAS were associated with slightly higher childhood BMI z-score and risk of overweight or obesity. Future studies should examine associations of gestational exposure to PFAS with adiposity and related cardiometabolic consequences in older children. https://doi.org/10.1289/EHP11545.
Export to EndNote